Prof. Dr. med. Thomas Hundsberger
Klinik für Neurologie (50%)
Klinik für Hämatologie und medizinische Onkologie (50%)
Ko-Leitung Zentrum für seltene Erkrankungen Ostschweiz (ZSK-O)
Interdisziplinäre Neuro-onkologische Ambulanz
Dozentur Universität St. Gallen (HSG)
Themenblockkoordinator Nervensystem im Joint Medical Master UZH/HSG
Leitende(r) Arzt/Ärztin
Neurologie, Medizinische Onkologie und Hämatologie · Dept. III, Dept. I
Immune triggers preceding neuralgic amyotrophy.
Sparasci D, Schilg-Hafer L, Schreiner B, Scheidegger O, Peyer A, Lascano A, Vicino A, Décard B, Tsouni P, Humm A, Pianezzi E, Zezza G, Hundsberger T, Dietmann A, Jung H, Kuntzer T, Wilder-Smith E, Martinetti-Lucchini G, Petrini O, Fontana S, Gowland P, Niederhauser C, Gobbi C, Ripellino P. Immune triggers preceding neuralgic amyotrophy. Eur J Neurol 2024; 31:e16462.
04.10.2024Immune triggers preceding neuralgic amyotrophy.
04.10.2024Eur J Neurol 2024; 31:e16462
Sparasci Davide, Schilg-Hafer Lenka, Schreiner Bettina, Scheidegger Olivier, Peyer Anne-Kathrin, Lascano Agustina Maria, Vicino Alex, Décard Bernhard Friedrich, Tsouni Pinelopi, Humm Andrea Monika, Pianezzi Enea, Zezza Giulia, Hundsberger Thomas, Dietmann Anelia, Jung Hans H, Kuntzer Thierry, Wilder-Smith Einar, Martinetti-Lucchini Gladys, Petrini Orlando, Fontana Stefano, Gowland Peter, Niederhauser Christoph, Gobbi Claudio, Ripellino Paolo
Improving outcome measures in late onset Pompe disease: Modified Rasch-Built Pompe-Specific Activity scale.
van Kooten H, Horton M, Wenninger S, Babačić H, Schoser B, Lefeuvre C, Taouagh N, Laforet P, Segovia S, Diaz-Manera J, Claeys K, Mongini T, Musumeci O, Toscano A, Hundsberger T, Brusse E, van Doorn P, van der Ploeg A, van der Beek N, European Pompe Consortium study group on outcome measures. Improving outcome measures in late onset Pompe disease: Modified Rasch-Built Pompe-Specific Activity scale. Eur J Neurol 2024; 31:e16397.
28.08.2024Improving outcome measures in late onset Pompe disease: Modified Rasch-Built Pompe-Specific Activity scale.
28.08.2024Eur J Neurol 2024; 31:e16397
van Kooten Harmke A, Horton Mike C, Wenninger Stephan, Babačić Haris, Schoser Benedikt, Lefeuvre Claire, Taouagh Najib, Laforet Pascal, Segovia Sonia, Diaz-Manera Jordi, Claeys Kristl G, Mongini Tiziana, Musumeci Olimpia, Toscano Antonio, Hundsberger Thomas, Brusse Esther, van Doorn Pieter A, van der Ploeg Ans T, van der Beek Nadine A M E, European Pompe Consortium study group on outcome measures
Start, switch and stop (triple-S) criteria for enzyme replacement therapy of late-onset Pompe disease: European Pompe Consortium recommendation update 2024.
Schoser B, van der Beek N, Broomfield A, Brusse E, Diaz-Manera J, Hahn A, Hundsberger T, Kornblum C, Kruijshaar M, Laforet P, Mengel E, Mongini T, Orlikowski D, Parenti G, Pijnappel W, Roberts M, Scherer T, Toscano A, Vissing J, O'Sullivan J, van Doorn P, Wenninger S, van der Ploeg A. Start, switch and stop (triple-S) criteria for enzyme replacement therapy of late-onset Pompe disease: European Pompe Consortium recommendation update 2024. Eur J Neurol 2024; 31:e16383.
14.06.2024Start, switch and stop (triple-S) criteria for enzyme replacement therapy of late-onset Pompe disease: European Pompe Consortium recommendation update 2024.
14.06.2024Eur J Neurol 2024; 31:e16383
Schoser Benedikt, van der Beek Nadine A M E, Broomfield Alexander, Brusse Esther, Diaz-Manera Jordi, Hahn Andreas, Hundsberger Thomas, Kornblum Cornelia, Kruijshaar Michelle E, Laforet Pascal, Mengel Eugen, Mongini Tiziana, Orlikowski David, Parenti Giancarlo, Pijnappel W W M Pim, Roberts Mark, Scherer Thomas, Toscano Antonio, Vissing John, O'Sullivan Joe M, van Doorn Pieter A, Wenninger Stephan, van der Ploeg Ans T
Temporal evolution of primary angiitis of the central nervous system (PACNS) on MRI following immunosuppressant treatment.
Wagner F, Almeida G, Willems E, Weber J, Geiss J, Hundsberger T, Mordasini P, Wildermuth S, Leschka S, Wälti S, Dietrich T, Fischer T. Temporal evolution of primary angiitis of the central nervous system (PACNS) on MRI following immunosuppressant treatment. Insights Imaging 2024; 15:140.
09.06.2024Temporal evolution of primary angiitis of the central nervous system (PACNS) on MRI following immunosuppressant treatment.
09.06.2024Insights Imaging 2024; 15:140
Wagner Franca, Almeida Gonçalo G, Willems Erik, Weber Johannes, Geiss Johannes, Hundsberger Thomas, Mordasini Pasquale, Wildermuth Simon, Leschka Sebastian, Wälti Stephan, Dietrich Tobias Johannes, Fischer Tim Steffen
A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol.
Mastall M, Roth P, Bink A, Maranta A, Läubli H, Hottinger A, Hundsberger T, Migliorini D, Ochsenbein A, Seystahl K, Imbach L, Hortobágyi T, Held L, Weller M, Wirsching H. A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol. BMC cancer 2024; 24:82.
15.01.2024A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol.
15.01.2024BMC cancer 2024; 24:82
Mastall Maximilian, Roth Patrick, Bink Andrea, Maranta Angela Fischer, Läubli Heinz, Hottinger Andreas Felix, Hundsberger Thomas, Migliorini Denis, Ochsenbein Adrian F, Seystahl Katharina, Imbach Lukas L, Hortobágyi Tibor, Held Leonhard, Weller Michael, Wirsching Hans-Georg
Laser Interstitial Thermal Therapy in a Large Thalamic Glioma with Long-Term Remission: A Case Report.
Hoyningen A, Koster K, Neidert M, Bozinov O, Lauber A, Kim O, Hundsberger T, Krüger M. Laser Interstitial Thermal Therapy in a Large Thalamic Glioma with Long-Term Remission: A Case Report. Oncol Res Treat 2023; 47:42-48.
26.12.2023Laser Interstitial Thermal Therapy in a Large Thalamic Glioma with Long-Term Remission: A Case Report.
26.12.2023Oncol Res Treat 2023; 47:42-48
Hoyningen Alexander, Koster Kira-Lee, Neidert Marian Christoph, Bozinov Oliver, Lauber Arno, Kim Olaf Chan-Hi, Hundsberger Thomas, Krüger Marie Therese
Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and older.
Stadler C, Gramatzki D, Le Rhun E, Hottinger A, Hundsberger T, Roelcke U, Läubli H, Hofer S, Seystahl K, Wirsching H, Weller M, Roth P. Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and older. Neurooncol Pract 2023; 11:132-141.
20.10.2023Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and older.
20.10.2023Neurooncol Pract 2023; 11:132-141
Stadler Christina, Gramatzki Dorothee, Le Rhun Emilie, Hottinger Andreas Felix, Hundsberger Thomas, Roelcke Ulrich, Läubli Heinz, Hofer Silvia, Seystahl Katharina, Wirsching Hans-Georg, Weller Michael, Roth Patrick
Neuropathies related to hepatitis E virus infection: A prospective, matched case-control study.
Ripellino P, Lascano A, Scheidegger O, Schilg-Hafer L, Schreiner B, Tsouni P, Vicino A, Peyer A, Humm A, Décard B, Pianezzi E, Zezza G, Sparasci D, Hundsberger T, Dietmann A, Jung H, Kuntzer T, Wilder-Smith E, Martinetti-Lucchini G, Petrini O, Fontana S, Gowland P, Niederhauser C, Gobbi C. Neuropathies related to hepatitis E virus infection: A prospective, matched case-control study. Eur J Neurol 2023; 31:e16030.
25.08.2023Neuropathies related to hepatitis E virus infection: A prospective, matched case-control study.
25.08.2023Eur J Neurol 2023; 31:e16030
Ripellino Paolo, Lascano Agustina Maria, Scheidegger Olivier, Schilg-Hafer Lenka, Schreiner Bettina, Tsouni Pinelopi, Vicino Alex, Peyer Anne-Kathrin, Humm Andrea Monika, Décard Bernhard Friedrich, Pianezzi Enea, Zezza Giulia, Sparasci Davide, Hundsberger Thomas, Dietmann Anelia, Jung Hans H, Kuntzer Thierry, Wilder-Smith Einar, Martinetti-Lucchini Gladys, Petrini Orlando, Fontana Stefano, Gowland Peter, Niederhauser Christoph, Gobbi Claudio
Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections.
Schmitt C, Hoefsmit E, Fangmeier T, Kramer N, Kabakci C, González-Navajas J, Versluis J, Compter A, Harrer T, Mijočević H, Schubert S, Hundsberger T, Menzies A, Scolyer R, Long G, French L, Blank C, Heinzerling L. Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections. Cancer Immunol Immunother 2023
22.08.2023Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections.
22.08.2023Cancer Immunol Immunother 2023
Schmitt Christina, Hoefsmit E P, Fangmeier T, Kramer N, Kabakci C, González-Navajas Jose M, Versluis Judith M, Compter Annette, Harrer T, Mijočević H, Schubert Steffen, Hundsberger Thomas, Menzies A M, Scolyer Richard A, Long Georgina V, French Lars Einar, Blank Christian U, Heinzerling Lucie M
Immune checkpoint inhibitors induced side effects of the peripheral nervous system.
Hundsberger T, Schreiner B, Roth P. Immune checkpoint inhibitors induced side effects of the peripheral nervous system. Curr Opin Neurol 2023; 36:427-431.
24.07.2023Immune checkpoint inhibitors induced side effects of the peripheral nervous system.
24.07.2023Curr Opin Neurol 2023; 36:427-431
Hundsberger Thomas, Schreiner Bettina, Roth Patrick
Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study.
Filippidis P, Damas J, Viala B, Assal F, Tshikung O, Tarr P, Derfuss T, Oberholzer M, Jelcic I, Hundsberger T, Sacco L, Cavassini M, Du Pasquier R, Darling K, NAMACO Study Group, Swiss HIV Cohort Study. Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study. J Acquir Immune Defic Syndr 2023; 93:219-228.
01.07.2023Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study.
01.07.2023J Acquir Immune Defic Syndr 2023; 93:219-228
Filippidis Paraskevas, Damas José, Viala Benjamin, Assal Frédéric, Tshikung Olivier Nawej, Tarr Philip X00a0 E, Derfuss Tobias, Oberholzer Michael, Jelcic Ilijas, Hundsberger Thomas, Sacco Leonardo, Cavassini Matthias, Du Pasquier Renaud A, Darling Katharine Elizabeth Anna, NAMACO Study Group, Swiss HIV Cohort Study
Correlation between age and the sciatic nerve diameter in the first 2 years of life: A high-resolution ultrasound study.
Jenny C, van der Linde J, Hundsberger T, Broser P. Correlation between age and the sciatic nerve diameter in the first 2 years of life: A high-resolution ultrasound study. Brain Behav 2023; 13:e2944.
22.03.2023Correlation between age and the sciatic nerve diameter in the first 2 years of life: A high-resolution ultrasound study.
22.03.2023Brain Behav 2023; 13:e2944
Jenny Carole, van der Linde Jacoba, Hundsberger Thomas, Broser Philip Julian
Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study.
Jörger M, Hundsberger T, Haefliger S, von Moos R, Hottinger A, Kaindl T, Engelhardt M, Marszewska M, Lane H, Roth P, Stathis A. Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study. Invest New Drugs 2023; 41:267-275.
16.02.2023Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study.
16.02.2023Invest New Drugs 2023; 41:267-275
Jörger Markus, Hundsberger Thomas, Haefliger Simon, von Moos Roger, Hottinger Andreas F, Kaindl Thomas, Engelhardt Marc, Marszewska Michalina, Lane Heidi, Roth Patrick, Stathis Anastasios
Laser Interstitial Thermal Therapy for Radionecrosis.
Terrapon A, Krüger M, Hundsberger T, Neidert M, Bozinov O. Laser Interstitial Thermal Therapy for Radionecrosis. Neurosurg Clin N Am 2023; 34:209-225.
31.01.2023Laser Interstitial Thermal Therapy for Radionecrosis.
31.01.2023Neurosurg Clin N Am 2023; 34:209-225
Terrapon Alexis Paul Romain, Krüger Marie Therese, Hundsberger Thomas, Neidert Marian Christoph, Bozinov Oliver
Von-Hippel-Lindau-Erkrankung
Koster K, Rothermundt C, Binet F, Borovicka J, Bozinov O, Clerici T, Engeler D, Greiner J, Hader C, Heinimann K, Azzarello-Burri S, Lang C, Krull I, Stöckli S, Omlin A, Hundsberger T. Von-Hippel-Lindau-Erkrankung - Interdisziplinäre Betreuung und neue therapeutische Optionen. Swiss Med Forum 2022; 48:4-784-787.
30.11.2022Von-Hippel-Lindau-Erkrankung
30.11.2022Swiss Med Forum 2022; 48:4-784-787
Koster Kira-Lee, Rothermundt Christian, Binet Françoise-Isabelle, Borovicka Jan, Bozinov Oliver, Clerici Thomas, Engeler Daniel, Greiner J, Hader Claudia, Heinimann Karl, Azzarello-Burri Silvia, Lang Corina, Krull Ina, Stöckli Sandro, Omlin Aurelius, Hundsberger Thomas
Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis.
Müller-Jensen L, Zierold S, Versluis J, Boehmerle W, Huehnchen P, Endres M, Mohr R, Compter A, Blank C, Hagenacker T, Meier F, Reinhardt L, Gesierich A, Salzmann M, Hassel J, Ugurel S, Zimmer L, Banks P, Spain L, Soon J, Enokida T, Tahara M, Kähler K, Seggewiss-Bernhardt R, Harvey C, Long G, Schöberl F, von Baumgarten L, Hundsberger T, Schlaak M, French L, Knauss S, Heinzerling L. Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis. Data Brief 2022; 45:108649.
30.09.2022Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis.
30.09.2022Data Brief 2022; 45:108649
Müller-Jensen Leonie, Zierold Sarah, Versluis Judith M, Boehmerle Wolfgang, Huehnchen Petra, Endres Matthias, Mohr Raphael, Compter Annette, Blank Christian U, Hagenacker Tim, Meier Friedegund, Reinhardt Lydia, Gesierich Anja, Salzmann Martin, Hassel Jessica C, Ugurel Selma, Zimmer Lisa, Banks Patricia, Spain Lavinia, Soon Jennifer A, Enokida Tomohiro, Tahara Makoto, Kähler Katharina C, Seggewiss-Bernhardt Ruth, Harvey Catriona, Long Georgina V, Schöberl Florian, von Baumgarten Louisa, Hundsberger Thomas, Schlaak Max, French Lars E, Knauss Samuel, Heinzerling Lucie M
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study.
Müller-Jensen L, Zierold S, Versluis J, Boehmerle W, Huehnchen P, Endres M, Mohr R, Compter A, Blank C, Hagenacker T, Meier F, Reinhardt L, Gesierich A, Salzmann M, Hassel J, Ugurel S, Zimmer L, Banks P, Spain L, Soon J, Enokida T, Tahara M, Kähler K, Seggewiss-Bernhardt R, Harvey C, Long G, Schöberl F, von Baumgarten L, Hundsberger T, Schlaak M, French L, Knauss S, Heinzerling L. Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study. Eur J Cancer 2022; 175:224-235.
22.09.2022Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study.
22.09.2022Eur J Cancer 2022; 175:224-235
Müller-Jensen Leonie, Zierold Sarah, Versluis Judith M, Boehmerle Wolfgang, Huehnchen Petra, Endres Matthias, Mohr Raphael, Compter Annette, Blank Christian U, Hagenacker Tim, Meier Friedegund, Reinhardt Lydia, Gesierich Anja, Salzmann Martin, Hassel Jessica C, Ugurel Selma, Zimmer Lisa, Banks Patricia, Spain Lavinia, Soon Jennifer A, Enokida Tomohiro, Tahara Makoto, Kähler Katharina C, Seggewiss-Bernhardt Ruth, Harvey Catriona, Long Georgina V, Schöberl Florian, von Baumgarten Louisa, Hundsberger Thomas, Schlaak Max, French Lars E, Knauss Samuel, Heinzerling Lucie M
Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus.
Jakeman B, Scherrer A, Darling K, Damas J, Bieler-Aeschlimann M, Hasse B, Schlosser L, Hachfeld A, Gutbrod K, Tarr P, Calmy A, Assal F, Kunze U, Stoeckle M, Schmid P, Rossi S, Di Benedetto C, Du Pasquier R, Cavassini M, Marzolini C, Hundsberger T. Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus. Open Forum Infect Dis 2022; 9:ofac457.
02.09.2022Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus.
02.09.2022Open Forum Infect Dis 2022; 9:ofac457
Jakeman Bernadette, Scherrer Alexandra U, Darling Katharine E A, Damas José, Bieler-Aeschlimann Melanie, Hasse Barbara, Schlosser Ladina, Hachfeld Anna, Gutbrod Klemens, Tarr Philip E, Calmy Alexandra, Assal Frédéric, Kunze Ursula, Stoeckle Marcel, Schmid Patrick, Rossi Stefania, Di Benedetto Caroline, Du Pasquier Renaud, Cavassini Matthias, Marzolini Catia, Hundsberger Thomas
Correlation of age and the diameter of the cervical nerve roots C5 and C6 during the first 2 years of life analyzed by high-resolution ultrasound imaging.
van der Linde J, Jenny C, Hundsberger T, Broser P. Correlation of age and the diameter of the cervical nerve roots C5 and C6 during the first 2 years of life analyzed by high-resolution ultrasound imaging. Brain Behav 2022; 12:e2649.
10.07.2022Correlation of age and the diameter of the cervical nerve roots C5 and C6 during the first 2 years of life analyzed by high-resolution ultrasound imaging.
10.07.2022Brain Behav 2022; 12:e2649
van der Linde Jacoba, Jenny Carole, Hundsberger Thomas, Broser Philip
Symptom Burden in Glioblastoma: A Prospective Pilot Study from Diagnosis to First Progression.
Roelcke U, Schwyzer L, Zeitlberger A, Hundsberger T. Symptom Burden in Glioblastoma: A Prospective Pilot Study from Diagnosis to First Progression. Oncology 2022; 101:145-152.
01.07.2022Symptom Burden in Glioblastoma: A Prospective Pilot Study from Diagnosis to First Progression.
01.07.2022Oncology 2022; 101:145-152
Roelcke Ulrich, Schwyzer Lucia, Zeitlberger Anna Maria, Hundsberger Thomas